Launch of Revised Strategy of TB- HIV Cross Referrals Delhi State AIDS Control Society Govt. of Delhi By Dr A.K. Gupta MD (Pediatrics) Additional Project.

Slides:



Advertisements
Similar presentations
National T.B. Control Program Rotarys Unique Initiative Against T.B. Presented by PP Rtn. Deepak Ramnane Rotary Club of Koramangala.
Advertisements

HIV & TB. Worldwide TB is the most important opportunistic infection in HIV patients – its the commonest killer. Around 20 million people worldwide are.
World Health Organization TB Case Definitions
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
In the name of God Fariba Rezaeetalab Assistant Professor.
Diagnosis and Management of TB John Yates Consultant Infectious Diseases.
Integrating TB into PWID Services in Indonesia The Works in Progress Dr Siti Nadia, NAP Manager; Dr Dyah Erti Mustikawati, NTP Manager Melbourne AIDS Conference.
CARIES SPINE AND SPINAL STENOSIS
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT) Implications.
TB Screening in the Antenatal Care Setting in Malawi Symposium: Exploring the intersection between TB and maternal and neonatal health: from research to.
Diagnosis of TB.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Unit 5: IPT Isoniazid TB Preventive Therapy
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
“Don’t tell me TB is under control!” Understanding TB
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Progress of the Singapore TB Elimination Programme (STEP)
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
1 Tuberculosis and HIV HAIVN Harvard Medical School AIDS Initiative in Vietnam.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Coordinator: Kézdi- Zaharia E. Iringó First author: Magyar Júlia Coauthor: Gyerő Réka.
Ukrainian TB mortality assessment 2008: Low HIV awareness and access to ART for TB patients associated with high HIV related TB mortality Presenting author:
TB/HIV in the South-East Asia Region From Mekong to Bali: The scale up of TB/HIV collaborative activities in the Asia Pacific August 8-9, 2009 Bali, Indonesia.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
HIV/TB Integration in a Network of Voluntary Counseling/Testing Centers in HAITI Reynold Grand’Pierre MD, Marie Suze Jacquet MD, Jean W. Pape MD PEPFAR.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Screening for TB among risk groups in Cambodia Dr. Mao Tan Eang, NTP Director National Center for TB and Leprosy Control, Cambodia TAG Meeting, 9-12 December.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Extrapulmonary tuberculosis and HIV Outi Vehviläinen, MD Ilembula Lutheran Hospital
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Tuberculosis in Children and Young Adults
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
Dr Jalal Mohsin Uddin MBBS DTCD FCPS (Pulmonology) Dr Jalal Mohsin Uddin MBBS DTCD FCPS (Pulmonology)
Scaling-up Access to Paediatric ART in India Dr. B B Rewari National AIDS Control Organisation India XVII International AIDS Conference Mexico City, 7.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
Progress with intensified TB Case Finding in Nigeria
R Nagar 1, Debashish Kundu2, S Chandra2 , A Khanna1
William Burman Denver Public Health Tuberculosis Trials Consortium
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
World Health Organization
Progress in Implementation of TB/HIV Collaborative activities
Screening and diagnosing TB in PLHIV: Challenges and ways forward
Indian Scenario HIV Situation TB Situation
TB/HIV COLLABORATION IN UGANDA
TB Screening and Differentiated Service Delivery: State of the Art
Presentation transcript:

Launch of Revised Strategy of TB- HIV Cross Referrals Delhi State AIDS Control Society Govt. of Delhi By Dr A.K. Gupta MD (Pediatrics) Additional Project Director

Total population of 1.1 billion 400 million TB infected 2.3 million HIV-infected 0.9 million TB/HIV co-infected 1.8 million new TB cases 4% TB cases HIV-infected HIV-associated TB disease in India

Risk of TB in HIV Patients HIV patients are at an increased risk of: Acquiring latent TB Developing active TB once infected with M. tuberculosis Becoming re-infected with a second strain of TB Relapsing after stopping treatment Source: NACO Lifetime Risk of TB

Diagnosis of Tuberculosis in PLHAs Atypical presentations of TB are more common – Minimal pulmonary disease – Higher proportion of Extra-pulmonary disease Higher proportion of sputum smear negative pulmonary disease (22- 64%) Diagnosis of active disease often delayed

Early and Late Stages of HIV Infection Features Stage of HIV Infection EarlyLate Clinical Presentation Often resembles Post-primary TB (Adult Type) Often resembles primary TB Sputum Smear Result Often positiveOften negative Chest X-ray Appearance Often shows cavities  Atypical presentation, often infiltrates lower lung-field lesions, intra-thoracic lymph nodes & infrequent cavities

The effect of HIV infection on symptoms and signs of TB Symptom/signHIV positive (%) HIV negative (%) Dyspnea Fever Sweats Weight loss Diarrhea Hepatomegaly Splenomegaly Lymphadenopathy Chest 1994;106:1471-6

Sites of involvement and HIV status SiteHIV positive (%) HIV negative (%) Pulmonary Extrapulmonary Both Pleural Pericardial Lymph node J Trop Med Hygiene 1993;96:1-11

Common forms of Extrapulmonary TB among HIV-infected persons Nodal – peripheral nodes - cervical > axillary > inguinal – central nodes - mediastinal > hilar, intra- abdominal Disseminated disease Serosal - pleural, pericardial > ascites Central nervous system - meningitis, tuberculoma Soft tissue abscesses

Effects of HIV on TB One year mortality % (four times than TB in HIV negative with TB) Cause of death is complication other than TB due to accelerated progression of HIV Increased incidence of ADR to ATT Increased emergence of drug resistance

Revised Guidelines for starting ART for HIV TB co-infected patients All HIV infected TB patients need to be started on ART – with CD4 count <350 (in case of pulmonary TB) and – irrespective of CD4 count in case of extrapulmonary TB – within 2 weeks of starting ATT NACO, November 2008

Intensified Case Finding…I Intensified TB case finding at : Integrated Counseling and Testing Center: All clients with symptoms and signs of TB would be referred to the nearest RNTCP diagnostic and treatment facility (DMC ART Center: Screen all patients for the symptoms and signs of TB on a modified diagnostic algorithm including clinical suspicion and other investigations with CXR, USG etc. as required Care and support centers: Implement Intensified TB case finding by symptom screening on a regular basis and prompt referral system

Intensified Case Finding….II Intensified HIV case finding: Screening Tool: for the Health Care Providers to screen all patients for signs and symptoms of HIV and refer them for counseling and testing to the nearest ICTC.

Challenges in ICF Gap in the linkage between DMCs (12,444) and ICTCs (4810) and further linking them for treatment with ART centers (185) and care& support centers; CCCs (195). Different interventions/policies for areas with different HIV prevalence and HIV/TB co-infections Linkage to care, support and treatment since ART centers and the CCCs are not widely distributed Poor referral by the providers & paramedical staff, since HIV and TB, both are stigmatized diseases. Preference for private sector test

Ictc Data- TESTING & COUNSELLING Total no. of Pre-test counselling: Total testing: ( ) Total no of clients found HIV +ve:4946 (1.64% Gen + ANC) Total no. of Post test counselling: (96.16%) Total cross referral: 30065( ) Total co infection:696( )

ICTC to RNTCP & RNTCP to ICTC Cross Referrals Total no. of HIV +ve clients referred from ICTC to RNTCP:1659 Total no of HIV +ve clients reached RNTCP: 1122(67.63%) Detected TB in HIV +ve clients: 59(5.25%) Started DOTS-49, Started ART-31 Total referrals from RNTCP to ICTC:25807 Total no of TB clients found HIV +ve:446 (1.72%) Started DOTS-383, Started ART-200

ART TO RNTCP Total no of HIV +ve clients referred to RNTCP:1034 Detected TB in HIV +ve clients: 191 (18.47%) ATT started: 179 (93.71%) ART initiated- 133 (69.63%) NOTE= 6 out of state clients & 4 dead

ART Registartioin and CD4 Count Total HIV TB Coe infected Clients =696 ATT started: 615/696 (6 out of state clients & 4 dead) ie % started on DOTS ART registration of HIV-TB co-infected clients:605 ( 86.92%) No. of HIV TB co-infected clients tested for CD4 count:547 (90.41%) – No. of clients having CD4 count < 350: 390 (71.29%) – No. of clients having CD4 count >=350: 178 (32.71%) ART started in 349 /605 (57.58%)

Why Revision in Strategy is Required? –Evidence 1.ICTC to RNTCP referrals of HIV Positive cases with symptoms of TB? > 35% HIV positive cases lost to follow up Low Detection of TB- Only 5 % referred cases were diagnosed to have TB Only half of HIV-TB co-infected patients could be put on ART after starting DOTS. 2.ART centre to ICTC referrals of all HIV positive cases – >75% HIV positive cases get registered in HIV care 3.ART centre to RNTCP referral of HIV positive cases with symptoms suggestive of TB > 75% cases reach RNTCP High TB detection rate- > 18% detected with TB Approx. 70% initiated on ART after starting DOTS.

New Referral Forms

No. of DOTS centers supervi sed No. of the patient with HIV-TB Co- infection in last 6 months No. of patients with HIV-TB co- infection initiated on Tb Treatment No. of patients with HIV-TB co-infection initiated on Anti Retroviral Treatment No. of patients with HIV-TB co-infection who may have died Proforma I- Tracking Patients with HIV-TB Co-infection for initiation of Anti Retroviral Treatment after 2 weeks of ATT (to be filled by STS) Name of the District: …………………………………………… Name & Tel No. of District TB Supervisor -………………………….. Date Remarks- Pls send the information every month by10 th bymail-

S.N o. TB No. Name of DOTS centre Name of the patient with HIV-TB Co- infection Residential Address Date of Start of ATT On ART Yes- Y, No.- N If on ART, name of ART centre where getting ART Agree to Instructions of DOTS provider to go to ART Centre Yes-Y, No.-N Proforma II Tracking Patients with HIV-TB Co-infection for initiation of Anti Retroviral Treatment after 2 weeks of ATT (to be provided by STS through DOTS providers) Name of the District: …………………………………………… Name /Contact No. of STS-……………………………… Date- Remarks- Pls send the information by 10 th of every month by mail-

Thank You